The LIGHTLas 577 delivers true solid-state 2.0W of 577nm yellow laser energy. The yellow wavelength is strongly absorbed by hemoglobin and minimal xanthophyll absorption, so it lets you treat closer to the fovea with greater safety. That is why 577nm has become the gold standard for macular work.
Built on a diode-pumped Nd:YVO₄ and KTP solid-state architecture for stable output and long life, it handles your retinal and glaucoma workflow from one compact console.
Available as a standalone 577 nm console or in combo configurations with LIGHTLas SLT Deux-V or LIGHTLas YAG-V.
Clear outcomes for everyday care.
Macular and sub-macular treatment
Including diabetic macular edema and central serous retinopathy.
Diabetic retinopathy
Diabetic retinopathy and panretinal photocoagulation.
Vascular retinal conditions
Treatment well suited to vascular work.
The details that make the difference.
True solid-state 577nm yellow
2.0W of yellow-wavelength energy.
Minimal xanthophyll absorption
Safer treatment near the fovea.
Continuous wave and SP-Mode®
Continuous wave and SP-Mode® microsecond technology.
Durable architecture
Diode-pumped Nd:YVO₄ and KTP architecture for stable, durable output.
Flexible and combo-ready
Standalone 577 nm console or combo configurations with LIGHTLas SLT Deux-V or LIGHTLas YAG-V.
